Exact Mass: 568.287
Exact Mass Matches: 568.287
Found 120 metabolites which its exact mass value is equals to given mass value 568.287
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Leukotriene F4
Leukotriene F4 is an intermediate in Arachidonic acid metabolism. Leukotriene F4 is converted from Leukotriene E4 via the enzyme Transferases (EC 2.3.2.-).Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. Leukotriene F4 is an intermediate in Arachidonic acid metabolism. Leukotriene F4 is converted from Leukotriene E4 via the enzyme Transferases (EC 2.3.2.-).
Canesceol
Canesceol is isolated from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the USA. Isolated from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the USA.
11-alpha-O-beta-D-Glucopyranosyl-16alpha-O-methylneoquassin
11-alpha-O-beta-D-Glucopyranosyl-16alpha-O-methylneoquassin is a constituent of Quassia amara (Surinam quassia).
leukotriene-f4
leukotriene-f4, also known as LTF4, is classified as a member of the Leukotrienes. Leukotrienes are eicosanoids containing a hydroxyl group attached to the aliphatic chain of an arachidonic acid. Leukotrienes have four double bonds, three (and only three) of which are conjugated. leukotriene-f4 is considered to be practically insoluble (in water) and acidic
14-hydro-15-hydroxyajugapitin
A diterpenoid isolated from the aerial parts of Ajuga bracteosa and has been shown to exhibit antifeedant activity.
2alpha-Hydroxy-bipindogenin-3beta-O-(2-desoxy-beta-D-allosid)|2alpha-Hydroxy-bipindogenin-3beta-O-<2-desoxy-beta-D-allosid>
ajugamarin D1 ((12S)-18,19-diacetoxy-4alpha,6alpha,12-trihydroxy-1beta-<(2S)-2-methylbutanoyloxy>neo-clerod-13(14)-en-15,16-olide)|ajugamarin D1 [(12S)-18,19-diacetoxy-4alpha,6alpha,12-trihydroxy-1beta-((2S)-2-methylbutanoyloxy)neo-clerod-13(14)-en-15,16-olide]
6,6-dihydroxy-8,8-(3,7-dimethyl-2,6-octadienyl)-biisocoumarin|machilusmarin
3beta-[(O-beta-D-glucopyranosyl)oxy]-5alpha,14beta,17beta-trihydroxycard-20(22)-enolide
19-(glucosyloxy)-3beta,5,14-trihydroxy-5beta-card-20(22)-enolide
10beta-hydroxy-19-nor-antiarigenin-3-O-beta-D-javopyranoside|toxicarioside H
Ala His Arg Trp
Ala His Trp Arg
Ala Arg His Trp
Ala Arg Trp His
Ala Trp His Arg
Ala Trp Arg His
Cys Lys Arg Tyr
Cys Lys Tyr Arg
Cys Arg Lys Tyr
Cys Arg Tyr Lys
Cys Tyr Lys Arg
Cys Tyr Arg Lys
His Ala Arg Trp
His Ala Trp Arg
His Arg Ala Trp
His Arg Trp Ala
His Trp Ala Arg
His Trp Arg Ala
Lys Cys Arg Tyr
Lys Cys Tyr Arg
Lys Arg Cys Tyr
Lys Arg Tyr Cys
Lys Tyr Cys Arg
Lys Tyr Arg Cys
Arg Ala His Trp
Arg Ala Trp His
Arg Cys Lys Tyr
Arg Cys Tyr Lys
Arg His Ala Trp
Arg His Trp Ala
Arg Lys Cys Tyr
Arg Lys Tyr Cys
Arg Trp Ala His
Arg Trp His Ala
Arg Tyr Cys Lys
Arg Tyr Lys Cys
Trp Ala His Arg
Trp Ala Arg His
Trp His Ala Arg
Trp His Arg Ala
Trp Arg Ala His
Trp Arg His Ala
Tyr Cys Lys Arg
Tyr Cys Arg Lys
Tyr Lys Cys Arg
Tyr Lys Arg Cys
Tyr Arg Cys Lys
Tyr Arg Lys Cys
11-a-O-b-D-Glucopyranosyl-16a-O-methylneoquassin
Leukotriene F4
A leukotriene composed of (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid having (5S)-hydroxy and (6R)-(L-gamma-glutamyl-L-cystein-S-yl) substituents.
Acaulesterone
1,1-(2,2-Dimethyl-[1,1-biphenyl]-4,4-diyl)bis(3,6-dimethyl-9H-carbazole)
9,10-Bis[N,N-di-(p-tolyl)-amino]anthracene
D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
(1aR,5S,8S,10R,22aR)-5-(1,1-Dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid methyl ester
1,3,2-Dioxaborolane, 2,2-(9,9-spirobi[9H-fluorene]-2,7-diyl)bis[4,4,5,5-tetramethyl-
2,6-Dimethylphenyl (2,4-dimethoxyphenyl)(2-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)carbamate
S-tetradecanoyl-4-phosphopantetheine
An S-acyl-4-phosphopantetheine obtained by formal condensation of the thiol group of D-pantetheine 4-phosphate with the carboxy group of tetradecanoic acid.
11-alpha-O-beta-D-Glucopyranosyl-16alpha-O-methylneoquassin
n-[2-(chloromethylidene)-6-[2-(hydroxymethyl)-3-methoxy-5-oxo-2h-pyrrol-1-yl]-4-methoxy-6-oxohex-4-en-1-yl]-7-methoxytetradec-4-enimidic acid
4-[(1r,3as,3br,5as,7s,9ar,9bs,11r,11as)-3a,5a,11-trihydroxy-9a-(hydroxymethyl)-11a-methyl-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-5h-furan-2-one
(1r,4r,7s,9r)-6-hydroxy-9-[(1r,4r,7s,9r)-6-hydroxy-4-isopropyl-3-oxo-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-9-yl]-4-isopropyl-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one
bipindogenin-3-o-β-d-allopyranoside
{"Ingredient_id": "HBIN018541","Ingredient_name": "bipindogenin-3-o-\u03b2-d-allopyranoside","Alias": "NA","Ingredient_formula": "C29H44O11","Ingredient_Smile": "CC12CCC(CC1(CCC3C2C(CC4(C3(CCC4C5=CC(=O)OC5)O)C)O)O)OC6C(C(C(C(O6)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2400","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}